Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 1
1954 1
1963 1
1969 1
1971 1
1972 2
1973 1
1974 4
1975 13
1976 19
1977 12
1978 14
1979 20
1980 22
1981 39
1982 42
1983 35
1984 59
1985 56
1986 63
1987 76
1988 72
1989 107
1990 100
1991 86
1992 133
1993 147
1994 160
1995 169
1996 202
1997 200
1998 198
1999 217
2000 245
2001 233
2002 271
2003 368
2004 317
2005 327
2006 379
2007 461
2008 459
2009 530
2010 578
2011 623
2012 673
2013 766
2014 820
2015 864
2016 923
2017 869
2018 957
2019 1107
2020 1189
2021 1186
2022 1252
2023 1205
2024 423

Text availability

Article attribute

Article type

Publication date

Search Results

16,835 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Advanced Malignant Genitourinary System Neoplasm"
Page 1
Adaptive Immunity in Genitourinary Cancers.
Koti M, Bivalacqua T, Black PC, Cathomen T, Galsky MD, Gulley JL, Ingersoll MA, Kamat AM, Kassouf W, Siemens DR, Gao J. Koti M, et al. Eur Urol Oncol. 2023 Jun;6(3):263-272. doi: 10.1016/j.euo.2023.03.002. Epub 2023 Apr 15. Eur Urol Oncol. 2023. PMID: 37069029 Free article. Review.
OBJECTIVE: To review the literature and describe the key adaptive immune physiological events associated with cancer progression and therapeutic response in genitourinary (GU) cancers. EVIDENCE ACQUISITION: We performed a nonsystematic, collaborative narrative review to hi …
OBJECTIVE: To review the literature and describe the key adaptive immune physiological events associated with cancer progression and therape …
Systematic review and meta-analysis of prediction models used in cervical cancer.
Jha AK, Mithun S, Sherkhane UB, Jaiswar V, Osong B, Purandare N, Kannan S, Prabhash K, Gupta S, Vanneste B, Rangarajan V, Dekker A, Wee L. Jha AK, et al. Artif Intell Med. 2023 May;139:102549. doi: 10.1016/j.artmed.2023.102549. Epub 2023 Apr 11. Artif Intell Med. 2023. PMID: 37100501 Free article. Review.
We developed a scoring system to evaluate the manuscript. As per our criteria, studies were divided into four groups based on scores obtained in our scoring system, the Most significant study (Score > 60 %); Significant study (60 % &gt …
We developed a scoring system to evaluate the manuscript. As per our criteria, studies were divided into four groups based on …
Nephrometric scoring system: Recent advances and outlooks.
Xiao Y, Shan ZJ, Yang JF, Len JJ, Yu YH, Yang ML. Xiao Y, et al. Urol Oncol. 2023 Jan;41(1):15-26. doi: 10.1016/j.urolonc.2022.06.019. Epub 2022 Jul 28. Urol Oncol. 2023. PMID: 35907706 Review.
A nephrometry scoring system is a key standard to evaluate the feasibility of partial nephrectomy (PN). Whether based on two-dimensional or three-dimensional images, simplicity, effectiveness, and practicality are the keys to the nephrometric scoring syste …
A nephrometry scoring system is a key standard to evaluate the feasibility of partial nephrectomy (PN). Whether based on two-d …
Imaging bladder cancer.
Cowan NC, Crew JP. Cowan NC, et al. Curr Opin Urol. 2010 Sep;20(5):409-13. doi: 10.1097/MOU.0b013e32833cbcb9. Curr Opin Urol. 2010. PMID: 20625298 Review.
PURPOSE OF REVIEW: To review recent developments in imaging for bladder cancer (BCa) diagnosis and staging. RECENT FINDINGS: Recent technical advances in multidetector computed tomography (CT) and, especially, CT urography make CT the preferred imaging modality for diagnos …
PURPOSE OF REVIEW: To review recent developments in imaging for bladder cancer (BCa) diagnosis and staging. RECENT FINDINGS: Recent technica …
Pediatric genitourinary tumors.
Merguerian PA. Merguerian PA. Curr Opin Oncol. 2003 May;15(3):222-6. doi: 10.1097/00001622-200305000-00008. Curr Opin Oncol. 2003. PMID: 12778016 Review.
Advances continue to be made in the evaluation and treatment of genitourinary tumors in children. Continued research on the cellular, molecular, and genetic process in tumorigenesis is rapidly evolving. We review the 2002 literature on pediatric genitourinary …
Advances continue to be made in the evaluation and treatment of genitourinary tumors in children. Continued research on the ce …
Pharmacogenomics: Biomarker-Directed Therapy for Bladder Cancer.
Jones RT, Felsenstein KM, Theodorescu D. Jones RT, et al. Urol Clin North Am. 2016 Feb;43(1):77-86. doi: 10.1016/j.ucl.2015.08.007. Epub 2015 Oct 31. Urol Clin North Am. 2016. PMID: 26614030 Free PMC article. Review.
The clinical management of bladder cancer has seen little change over the last three decades and there is pressing need to identify more effective treatments for advanced disease. Low clinical use of neoadjuvant therapies stems from historical limitations in the ability to …
The clinical management of bladder cancer has seen little change over the last three decades and there is pressing need to identify more eff …
Robotic-Assisted Laparoscopic Radical Prostatectomy.
Agarwal G, Valderrama O, Luchey AM, Pow-Sang JM. Agarwal G, et al. Cancer Control. 2015 Jul;22(3):283-90. doi: 10.1177/107327481502200305. Cancer Control. 2015. PMID: 26351883 Free article. Review.
A nonsystematic review was utilized to describe the advancements in the techniques used for RALRP. RESULTS: RALRP is the procedure of choice when treating localized prostate cancer. ...CONCLUSIONS: Morbidity rates should continue to improve with the advancement of m …
A nonsystematic review was utilized to describe the advancements in the techniques used for RALRP. RESULTS: RALRP is the procedure of …
Consensus on molecular imaging and theranostics in prostate cancer.
Fanti S, Minozzi S, Antoch G, Banks I, Briganti A, Carrio I, Chiti A, Clarke N, Eiber M, De Bono J, Fizazi K, Gillessen S, Gledhill S, Haberkorn U, Herrmann K, Hicks RJ, Lecouvet F, Montironi R, Ost P, O'Sullivan JM, Padhani AR, Schalken JA, Scher HI, Tombal B, van Moorselaar RJA, Van Poppel H, Vargas HA, Walz J, Weber WA, Wester HJ, Oyen WJG. Fanti S, et al. Lancet Oncol. 2018 Dec;19(12):e696-e708. doi: 10.1016/S1470-2045(18)30604-1. Lancet Oncol. 2018. PMID: 30507436
Relevant conclusions included the following: diphosphonate bone scanning and contrast-enhanced CT are mentioned but rarely recommended for most patients in clinical guidelines; MRI (whole-body or multiparametric) and prostate cancer-targeted PET are frequently suggested, but the …
Relevant conclusions included the following: diphosphonate bone scanning and contrast-enhanced CT are mentioned but rarely recommended for m …
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.
Fagotti A, Ferrandina G, Fanfani F, Ercoli A, Lorusso D, Rossi M, Scambia G. Fagotti A, et al. Ann Surg Oncol. 2006 Aug;13(8):1156-61. doi: 10.1245/ASO.2006.08.021. Epub 2006 Jun 21. Ann Surg Oncol. 2006. PMID: 16791447
Each parameter was assigned a numerical score based on the strength of statistical association, and a total predictive index value was tabulated for each patient. ...CONCLUSIONS: The reliability of laparoscopy in assessing the chance of optimal cytoreduction can be …
Each parameter was assigned a numerical score based on the strength of statistical association, and a total predictive index v …
Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
Derosa L, Routy B, Fidelle M, Iebba V, Alla L, Pasolli E, Segata N, Desnoyer A, Pietrantonio F, Ferrere G, Fahrner JE, Le Chatellier E, Pons N, Galleron N, Roume H, Duong CPM, Mondragón L, Iribarren K, Bonvalet M, Terrisse S, Rauber C, Goubet AG, Daillère R, Lemaitre F, Reni A, Casu B, Alou MT, Alves Costa Silva C, Raoult D, Fizazi K, Escudier B, Kroemer G, Albiges L, Zitvogel L. Derosa L, et al. Eur Urol. 2020 Aug;78(2):195-206. doi: 10.1016/j.eururo.2020.04.044. Epub 2020 May 4. Eur Urol. 2020. PMID: 32376136 Free article.
OBJECTIVE: To evaluate the predictive value of stool bacteria composition for ICB efficacy in a cohort of advanced RCC patients. DESIGN, SETTING, AND PARTICIPANTS: We prospectively collected fecal samples from 69 advanced RCC patients treated with nivolumab a …
OBJECTIVE: To evaluate the predictive value of stool bacteria composition for ICB efficacy in a cohort of advanced RCC patient …
16,835 results
You have reached the last available page of results. Please see the User Guide for more information.